CAVE CREEK, AZ--(Marketwired - Jun 23, 2014) - Endexx Corporation (OTC Pink: EDXC) ( PINKSHEETS : EDXC ), a provider of innovative medical marijuana management and technology solutions, announced today that it has secured a site location to test its Autospense™ technology in the Colorado market. The dispensary is a well-known, high volume dispensary licensed in medical and recreational marijuana sales. The 100-day pilot program is designed to test for compliance and tracking integration under the Medical Marijuana Infused Products Manufacturing License program ("MIPS") regulated by the Marijuana Enforcement Division of Colorado. During the program, a goal is to collect measurable data on dispensary clients' behavior, market test adoption drivers and collect valuable intelligence on the ways Autospense can enhance profitability to store owners, offset labor costs, assist in inventory management, eliminate client wait time and increase customer loyalty and satisfaction.

The program will be put in place for an initial 100 day trial period, followed by a lease option on the equipment. Endexx is pursuing similar market testing ventures with dominant licensed retailers in newly legalized markets.

Endexx's Autospense™ is a high-tech marijuana inventory control and dispensing machine, which provides up to the minute accounting details, monitoring and tracking of inventory, and provides verification and safety for the product as well as patients and customers of the dispensaries. Autospense™ increases productivity and reduces costs for marijuana retailers, while enhancing their service quality by reducing transaction time for customers. Endexx will be displaying the Autospense™ at the Weedstock Conference on June 30-July 2, 2014. After the conference has commenced, the unit will be shipped to the dispensary in Colorado. Endexx will announce more details of the launch following the conference.

"After intensive research and development we are very excited to launch Autospense™ into the first dispensary," said Todd Davis, Founder and CEO of Endexx Corporation. "Pharmaceutical-grade compliance is essential for the success of both the medical and recreational marijuana industries. Autospense™ is ideal for any dispensary and offers a cutting-edge solution that maintains full compliance with regulations. This launch is a huge milestone for us and positions us perfectly to grow within the industry. This is only the beginning as we look to roll out more Autospense™ machines in the coming months."

About Endexx
Endexx provides innovative medical marijuana management and technology solutions. The company has two products that launched in the first half of 2014 -- the M3hub and the Autospense™. Both products provide essential solutions to promote regulatory compliance and full accountability through "seed to sale" inventory management, process monitoring and tracking. Based on principles developed by the pharmacological industry, the m3hub database is the first standardized software platform for tracking pharmaceutical grade marijuana to support a Centralized Medical Marijuana Industry Repository and maintain compliance with the laws of the federal government and state and local regulatory bodies. The Autospense™ is a high-tech marijuana inventory control and dispensing machine, which provides up to the minute accounting details and protects the security of the product as well as the patient. By automating the dispensing process, Autospense™ increases productivity and reduces costs for marijuana retailers, while enhancing their service quality by reducing transaction time for customers. www.endexx.com , www.m3hub.com , www.autospense.com

Safe Harbor Notice
This press release may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities, and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the Company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company's ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with the Company's business and finances in general, including the ability to continue and manage its growth, competition, global economic conditions and other factors discussed in detail in the Company's periodic filings with the Security and Exchange Commission. The Company undertakes no obligation to update any forward-looking statements.